Identifying Patients With Suspicion of Infection in the ED Who Have Low Disease Severity Using MR-proADM - Pilot Study — IDEAL  

Patients Presenting With Suspicion of Infection to the ED Clinical Trial

Official title: Identifying Patients With Suspicion of Infection in the ED Who Have Low Disease Severity Using Midregional Proadrenomedullin (MR-proADM) - Pilot Study

Status Completed

Clinical Trial Summary

Emergency departments (ED) are becoming increasingly over-crowded, with patients facing prolonged waiting times. Therefore, a safe and rapid assessment that identifies patients with low severity that could be treated as outpatients is essential for improving the workflow within the ED.

The rationale of this IDEAL study is to provide guidance to safely decrease the number of hospital admissions through identification of low risk patients with the biomarker MR-proADM. This will be tested in a pilot study first.

Clinical Trial Description

n/a

Related Conditions & MeSH terms

• Communicable Diseases
• Infection
• Patients Presenting With Suspicion of Infection to the ED

• NCT number: NCT03770533
• Study type: Interventional
• Source: Brahms AG
• Status: Completed
• Phase: N/A
• Start date: December 14, 2018
• Completion date: December 11, 2019